Cathie Wood’s Ark Invest Bets on Beam Therapeutics, with Multiple Clinical Catalysts Expected to Densely Materialize Over the Next 18 Months Jul 20, 2026 Life Science
Anti-Cancer Upstart’s Stock Surges 125% This Year as Billionaire Druckenmiller Builds Large Position Jul 18, 2026 Life Science
Oral Wegovy Dominates. Is Eli Lilly’s Trillion-Dollar Valuation Still Safe? Jul 17, 2026 Life Science
Raising Dividends for 54 Consecutive Years to Reward Shareholders, Abbott Laboratories’ Diversified Layout Consolidates Its Growth Foundation Jul 17, 2026 Life Science
UnitedHealth Group Stock Rises 37% Year-to-Date, Market Sees Path Back to All-Time Highs Jul 16, 2026 Life Science
Intuitive Surgical’s Stock Has Fallen Over 25% This Year, but Goldman Sachs Still Recommends Investors Buy Jul 15, 2026 Life Science
Two Overhyped GLP-1 Stocks Present Buying Opportunities on Dips, with Novo Nordisk and Kailera Therapeutics Each Offering Unique Highlights Jul 14, 2026 Life Science
The Market Has Responded Coolly to Vertex’s Multibillion-Dollar Acquisition, but Management’s Track Record and Integration Capabilities Add Confidence to the Deal Jul 14, 2026 Life Science
Core Business Steady Growth Coupled with Acquisition Tailwinds, Vertex Pharmaceuticals Demonstrates Strong Post-Market Momentum Jul 11, 2026 Life Science
Pfizer Could Rewrite the GLP-1 Race — but Its 7% Yield Is Flashing a Warning Jul 10, 2026 Life Science
Incyte and TG Therapeutics Deliver Notable Growth, Drawing Investment Attention to the Biotech Sector Jul 9, 2026 Life Science
Vertex’s $10 Billion Crinetics Acquisition Lands Amid Record Stock High: Time to Buy? Jul 8, 2026 Life Science
Two Healthcare Blue-Chip Stocks Offer Opportunities as Dividends Shine Bright for Pfizer and Bristol-Myers Squibb Jul 8, 2026 Life Science
Biotech Double Winners Outperform the Market, With Fundamental Tailwinds Poised to Sustain Momentum Jul 7, 2026 Life Science
